Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial

Trial ID or NCT#

NCT02175225

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to determine whether treatment with Deferoxamine Mesylate is of sufficient promise to improve outcome before pursuing a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.

Investigator(s)

Chitra Venkatasubramanian, MD